| Gene expression correlates of clinical prostate cancer behavior D Singh, PG Febbo, K Ross, DG Jackson, J Manola, C Ladd, P Tamayo, ... Cancer cell 1 (2), 203-209, 2002 | 3119 | 2002 |
| Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer M Stanbrough, GJ Bubley, K Ross, TR Golub, MA Rubin, TM Penning, ... Cancer research 66 (5), 2815-2825, 2006 | 1354 | 2006 |
| mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways PK Majumder, PG Febbo, R Bikoff, R Berger, Q Xue, LM McMahon, ... Nature medicine 10 (6), 594-601, 2004 | 1138 | 2004 |
| Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression CK Anders, DS Hsu, G Broadwater, CR Acharya, JA Foekens, Y Zhang, ... Journal of clinical oncology 26 (20), 3324-3330, 2008 | 1077 | 2008 |
| Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target S Horvath, B Zhang, M Carlson, KV Lu, S Zhu, RM Felciano, MF Laurance, ... Proceedings of the National Academy of Sciences 103 (46), 17402-17407, 2006 | 744 | 2006 |
| A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling EA Klein, MR Cooperberg, C Magi-Galluzzi, JP Simko, SM Falzarano, ... European urology 66 (3), 550-560, 2014 | 725 | 2014 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 716 | 2021 |
| Genomic signatures to guide the use of chemotherapeutics A Potti, HK Dressman, A Bild, RF Riedel, G Chan, R Sayer, J Cragun, ... Nature medicine 12 (11), 1294-1300, 2006 | 666 | 2006 |
| Genomic hallmarks and structural variation in metastatic prostate cancer DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ... Cell 174 (3), 758-769. e9, 2018 | 633 | 2018 |
| Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma TA Read, MP Fogarty, SL Markant, RE McLendon, Z Wei, DW Ellison, ... Cancer cell 15 (2), 135-147, 2009 | 446 | 2009 |
| Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer T Migita, S Ruiz, A Fornari, M Fiorentino, C Priolo, G Zadra, F Inazuka, ... Journal of the National Cancer Institute 101 (7), 519-532, 2009 | 434 | 2009 |
| An animal model of MYC-driven medulloblastoma Y Pei, CE Moore, J Wang, AK Tewari, A Eroshkin, YJ Cho, H Witt, ... Cancer cell 21 (2), 155-167, 2012 | 377 | 2012 |
| Fatty acid synthase expression defines distinct molecular signatures in prostate cancer S Rossi, E Graner, P Febbo, L Weinstein, N Bhattacharya, T Onody, ... Molecular Cancer Research 1 (10), 707-715, 2003 | 370 | 2003 |
| A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with … J Cullen, IL Rosner, TC Brand, N Zhang, AC Tsiatis, J Moncur, A Ali, ... European urology 68 (1), 123-131, 2015 | 363 | 2015 |
| Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model PK Majumder, JJ Yeh, DJ George, PG Febbo, J Kum, Q Xue, R Bikoff, ... Proceedings of the National Academy of Sciences 100 (13), 7841-7846, 2003 | 334 | 2003 |
| Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers A Berchuck, ES Iversen, JM Lancaster, J Pittman, J Luo, P Lee, S Murphy, ... Clinical cancer research 11 (10), 3686-3696, 2005 | 319 | 2005 |
| NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology PG Febbo, M Ladanyi, KD Aldape, AM De Marzo, ME Hammond, ... Journal of the National Comprehensive Cancer Network 9 (Suppl_5), S-1-S-32, 2011 | 301 | 2011 |
| Emergence and rapid transmission of SARS-CoV-2 B. 1.1. 7 in the United States NL Washington, K Gangavarapu, M Zeller, A Bolze, ET Cirulli, ... Cell 184 (10), 2587-2594. e7, 2021 | 268 | 2021 |
| Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors JV Alvarez, PG Febbo, S Ramaswamy, M Loda, A Richardson, DA Frank Cancer research 65 (12), 5054-5062, 2005 | 247 | 2005 |
| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 231 | 2020 |
Todd GolubBroad InstituteVerified email at broadinstitute.org
